advertisement

---

Lee RK 13

Showing records 1 to 13 | Display all abstracts from Lee RK

112085 Cyclophotocoagulation as a Minimally Invasive Treatment Option for Glaucoma
Khodeiry MM
International Ophthalmology Clinics 2023; 63: 125-135

---

112753 Parvalbumin expression changes with retinal ganglion cell degeneration
Liu Y
Frontiers in neuroscience 2023; 17: 1227116

---

111852 Secondary glaucoma: Toward interventions based on molecular underpinnings
Müller A; Lam I
WIREs mechanisms of disease 2024; 16: e1628

---

112085 Cyclophotocoagulation as a Minimally Invasive Treatment Option for Glaucoma
Elhusseiny AM
International Ophthalmology Clinics 2023; 63: 125-135

---

112753 Parvalbumin expression changes with retinal ganglion cell degeneration
Cheng He R
Frontiers in neuroscience 2023; 17: 1227116

---

112085 Cyclophotocoagulation as a Minimally Invasive Treatment Option for Glaucoma
Liu X
International Ophthalmology Clinics 2023; 63: 125-135

---

111852 Secondary glaucoma: Toward interventions based on molecular underpinnings
Kishor K
WIREs mechanisms of disease 2024; 16: e1628

---

112753 Parvalbumin expression changes with retinal ganglion cell degeneration
Munguba GC
Frontiers in neuroscience 2023; 17: 1227116

---

111852 Secondary glaucoma: Toward interventions based on molecular underpinnings
Lee RK
WIREs mechanisms of disease 2024; 16: e1628

---

112085 Cyclophotocoagulation as a Minimally Invasive Treatment Option for Glaucoma
Sayed MS
International Ophthalmology Clinics 2023; 63: 125-135

---

112753 Parvalbumin expression changes with retinal ganglion cell degeneration
Lee RK
Frontiers in neuroscience 2023; 17: 1227116

---

112085 Cyclophotocoagulation as a Minimally Invasive Treatment Option for Glaucoma
Lee RK
International Ophthalmology Clinics 2023; 63: 125-135

---

111852 Secondary glaucoma: Toward interventions based on molecular underpinnings
Bhattacharya S
WIREs mechanisms of disease 2024; 16: e1628

---